Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer

Nature Communications

Volumn 7, Issue , 2016, Pages

  Puvirajesinghe, Tania M ^a,b,c,d   Bertucci, François ^b,c,d,e   Jain, Ashish ^f,g   Scerbo, Pierluigi ^h   Belotti, Edwige ^a,b,c,d,j   Audebert, Stéphane ^a,b,c,d   Sebbagh, Michael ^a,b,c,d   Lopez, Marc ^b,c,d,e   Brech, Andreas ^g   Finetti, Pascal ^b,c,d,e   Charafe Jauffret, Emmanuelle ^b,c,d,e   Chaffanet, Max ^b,c,d,e   Castellano, Rémy ^a,b,c,d   Restouin, Audrey ^a,b,c,d   Marchetto, Sylvie ^a,b,c,d   Collette, Yves ^a,b,c,d   Gonçalvès, Anthony ^a,b,c,d   Macara, Ian ⁱ   Birnbaum, Daniel ^b,c,d,e   Kodjabachian, Laurent ^h   Johansen, Terje ^f   Borg, Jean Paul ^a,b,c,d   more..

^a INSERM   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d CNRS   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

^f UNIVERSITY OF TROMSØ   (Norway)

^g UNIVERSITY OF OSLO   (Norway)

^h AIX MARSEILLE UNIVERSITÉ   (France)

ⁱ UNIVERSITY OF VIRGINIA   (United States)

^j UNIVERSITÉ DE LYON   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; P62 SEQUESTOSOME 1 PROTEIN; SCAFFOLD PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; VANGL2 PROTEIN; WNT PROTEIN; WNT5A PROTEIN; MEMBRANE PROTEIN; SEQUESTOSOME 1; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SQSTM1 PROTEIN, HUMAN; VANGL2 PROTEIN, HUMAN;

AGGRESSION; CANCER; EMBRYONIC DEVELOPMENT; GENE EXPRESSION; IDENTIFICATION METHOD; PROTEIN; SURVIVAL; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CARCINOGENESIS; CARCINOGENICITY; CELL MIGRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; FEMALE; GENE CLUSTER; GENE DOSAGE; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SELECTIVE AUTOPHAGY; SIGNAL TRANSDUCTION; UPREGULATION; XENOPUS; ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; CELL MIGRATION ASSAY; CELL MOTION; CELL POLARITY; CELL PROLIFERATION; COPY NUMBER VARIATION; ELECTRON MICROSCOPY; GENETICS; LUNG CARCINOMA; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; NONMAMMALIAN EMBRYO; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TUMOR CELL LINE; WESTERN BLOTTING; WNT SIGNALING PATHWAY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CELL LINE, TUMOR; CELL MIGRATION ASSAYS; CELL MOVEMENT; CELL POLARITY; CELL PROLIFERATION; DNA COPY NUMBER VARIATIONS; EMBRYO, NONMAMMALIAN; FEMALE; HUMANS; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MASS SPECTROMETRY; MEMBRANE PROTEINS; MICE; MICROSCOPY, ELECTRON; MIDDLE AGED; NEOPLASM TRANSPLANTATION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA, MESSENGER; SEQUESTOSOME-1 PROTEIN; WNT SIGNALING PATHWAY; XENOPUS;

EID: 84954496404     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10318     Document Type: Article

References (56)

1. Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98, 10869-10874 (2001).
2. Bertucci, F., Finetti, P. & Birnbaum, D. Basal breast cancer: a complex and deadly molecular subtype. Curr. Mol. Med. 12, 96-110 (2012).
3. Anastas, J. N. & Moon, R. T. WNT signalling pathways as therapeutic targets in cancer. Nat. Rev. Cancer 13, 11-26 (2013).
4. Lin, S. Y. et al. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc. Natl Acad. Sci. USA 97, 4262-4266 (2000).
5. Bukholm, I. K., Nesland, J. M., Karesen, R., Jacobsen, U. & Borresen-Dale, A. L. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. J. Pathol. 185, 262-266 (1998).
6. Khramtsov, A. I. et al. Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am. J. Pathol. 176, 2911-2920 (2010).
7. Luga, V. et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 151, 1542-1556 (2012).
8. Anastas, J. N. et al. A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression. Oncogene 31, 3696-3708 (2011).
9. Gujral, T. S. et al. A noncanonical frizzled2 pathway regulates epithelialmesenchymal transition and metastasis. Cell 159, 844-856 (2014).
10. Simons, M. & Mlodzik, M. Planar cell polarity signaling: from fly development to human disease. Annu. Rev. Genet. 42, 517-540 (2008).
11. Sebbagh, M. & Borg, J. P. Insight into planar cell polarity. Exp. Cell Res. 328, 284-295 (2014).
12. Lei, Y. P. et al. VANGL2 mutations in human cranial neural-tube defects. N. Engl. J. Med. 362, 2232-2235 (2010).
13. Tournier, C. The 2 faces of JNK signaling in cancer. Genes Cancer 4, 397-400 (2013).
14. Johansen, T. & Lamark, T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 7, 279-296 (2010).
15. Bertrand, M. et al. SQSTM1/p62 regulates the expression of junctional proteins through epithelial-mesenchymal transition factors. Cell Cycle 14, 364-374 (2015).
16. Moscat, J. & Diaz-Meco, M. T. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 137, 1001-1004 (2009).
17. Rolland, P. et al. The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease. Endocr. Relat. Cancer 14, 73-80 (2007).
18. Duran, A. et al. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell 13, 343-354 (2008).
19. Luo, R. Z. et al. Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer. Onco. Targets Ther. 6, 883-888 (2013).
20. Wei, H., Wang, C., Croce, C. M. & Guan, J. L. p62/SQSTM1 synergizes with autophagy for tumor growth in vivo. Genes Dev. 28, 1204-1216 (2014).
21. Belotti, E. et al. Molecular characterisation of endogenous Vangl2/Vangl1 heteromeric protein complexes. PLoS ONE 7, e46213 (2012).
22. Charafe-Jauffret, E. et al. Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 25, 2273-2284 (2006).
23. Belotti, E. et al. The human PDZome: a gateway to PDZ mediated functions. Mol. Cell Proteomics 12, 2587-2603 (2013).
24. McCaffrey, L. M., Montalbano, J., Mihai, C. & Macara, I. G. Loss of the Par3 polarity protein promotes breast tumorigenesis and metastasis. Cancer Cell 22, 601-614 (2012).
25. Pankiv, S. et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282, 24131-24145 (2007).
26. Park, M. & Moon, R. T. The planar cell-polarity gene stbm regulates cell behaviour and cell fate in vertebrate embryos. Nat. Cell Biol. 4, 20-25 (2002).
27. Lamark, T. et al. Interaction codes within the family of mammalian Phox and Bem1p domain-containing proteins. J. Biol. Chem. 278, 34568-34581 (2003).
28. Giese, A. P. et al. Gipc1 has a dual role in Vangl2 trafficking and hair bundle integrity in the inner ear. Development 139, 3775-3785 (2012).
29. Sanchez, P., De Carcer, G., Sandoval, I. V., Moscat, J. & Diaz-Meco, M. T. Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62. Mol. Cell Biol. 18, 3069-3080 (1998).
30. Gravel, M., Iliescu, A., Horth, C., Apuzzo, S. & Gros, P. Molecular and cellular mechanisms underlying neural tube defects in the loop-tail mutant mouse. Biochemistry 49, 3445-3455 (2010).
31. Darken, R. S. et al. The planar polarity gene strabismus regulates convergent extension movements in Xenopus. EMBO J. 21, 976-985 (2002).
32. Unterseher, F. et al. Paraxial protocadherin coordinates cell polarity during convergent extension via Rho A and JNK. EMBO J. 23, 3259-3269 (2004).
33. Schambony, A. & Wedlich, D. Wnt-5A/Ror2 regulate expression of XPAPC through an alternative noncanonical signaling pathway. Dev. Cell 12, 779-792 (2007).
34. Charafe-Jauffret, E. et al. ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program. Cancer Res. 73, 7290-7300 (2013).
35. Hatakeyama, J., Wald, J. H., Printsev, I., Ho, H. Y. & Carraway, 3rd K. L. Vangl1 and Vangl2: planar cell polarity components with a developing role in cancer. Endocr. Relat. Cancer 21, R345-R356 (2014).
36. Kaucka, M. et al. The planar cell polarity pathway drives pathogenesis of chronic lymphocytic leukemia by the regulation of B-lymphocyte migration. Cancer Res. 73, 1491-1501 (2013).
37. Archibald, A., Mihai, C., Macara, I. G. & McCaffrey, L. Oncogenic suppression of apoptosis uncovers a Rac1/JNK proliferation pathway activated by loss of Par3. Oncogene 34, 3199-3206 (2014).
38. Lindqvist, M. et al. Vang-like protein 2 and Rac1 interact to regulate adherens junctions. J. Cell Sci. 123, 472-483 (2010).
39. Whitmarsh, A. J. The JIP family of MAPK scaffold proteins. Biochem. Soc. Trans. 34, 828-832 (2006).
40. Cordenonsi, M. et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147, 759-772 (2011).
41. Wu, J. & Mlodzik, M. The frizzled extracellular domain is a ligand for Van Gogh/Stbm during nonautonomous planar cell polarity signaling. Dev. Cell 15, 462-469 (2008).
42. Devenport, D. & Fuchs, E. Planar polarization in embryonic epidermis orchestrates global asymmetric morphogenesis of hair follicles. Nat. Cell Biol. 10, 1257-1268 (2008).
43. Parameswaran, N., Enyindah-Asonye, G., Bagheri, N., Shah, N. B. & Gupta, N. Spatial coupling of JNK activation to the B cell antigen receptor by tyrosinephosphorylated ezrin. J. Immunol. 190, 2017-2026 (2013).
44. Duran, A. et al. p62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol. Cell 44, 134-146 (2011).
45. Bubici, C. & Papa, S. JNK signalling in cancer: in need of new, smarter therapeutic targets. Br. J. Pharmacol. 171, 24-37 (2014).
46. Yunokawa, M. et al. Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells. Cancer Sci. 103, 1665-1671 (2012).
47. Singh, J. et al. Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer. Breast Cancer Res. 16, R32 (2014).
48. Wang, Z. et al. Blocking autophagy enhanced cytotoxicity induced by recombinant human arginase in triple-negative breast cancer cells. Cell Death Dis. 5, e1563 (2014).
49. Luxardi, G., Marchal, L., Thome, V. & Kodjabachian, L. Distinct Xenopus Nodal ligands sequentially induce mesendoderm and control gastrulation movements in parallel to the Wnt/PCP pathway. Development 137, 417-426 (2010).
50. Irizarry, R. A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249-264 (2003).
51. Parker, J. S. et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27, 1160-1167 (2009).
52. Sabatier, R. et al. Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer. PLoS ONE 6, e27656 (2011).
53. Adelaide, J. et al. Integrated profiling of basal and luminal breast cancers. Cancer Res. 67, 11565-11575 (2007).
54. McShane, L. M. et al. REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res. Treat. 100, 229-235 (2006).
55. Qin, Y., Capaldo, C., Gumbiner, B. M. & Macara, I. G. The mammalian Scribble polarity protein regulates epithelial cell adhesion and migration through E-cadherin. J. Cell Biol. 171, 1061-1071 (2005).
56. Audebert, S. et al. Mammalian Scribble forms a tight complex with the betaPIX exchange factor. Curr. Biol. 14, 987-995 (2004).